Document/ExhibitDescriptionPagesSize 1: 8-K Current Report HTML 35K
2: EX-3.1 Articles of Incorporation/Organization or Bylaws HTML 36K
7: R1 Cover Page Document HTML 48K
9: XML IDEA XML File -- Filing Summary XML 11K
6: XML XBRL Instance -- mdxg-20210527_htm XML 23K
8: EXCEL IDEA Workbook of Financial Reports XLSX 6K
4: EX-101.LAB XBRL Labels -- mdxg-20210527_lab XML 70K
5: EX-101.PRE XBRL Presentations -- mdxg-20210527_pre XML 34K
3: EX-101.SCH XBRL Schema -- mdxg-20210527 XSD 10K
10: JSON XBRL Instance as JSON Data -- MetaLinks 12± 17K
11: ZIP XBRL Zipped Folder -- 0001376339-21-000083-xbrl Zip 20K
(Address of principal executive offices) (Zip Code)
Registrant’s
telephone number, including area code: (i770) i651-9100
____________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
(see General Instruction A.2. below):
i☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
i☐
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
i☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
i☐
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
iCommon
Stock, $0.001 par value per share
iMDXG
iThe Nasdaq Stock Market LLC
Indicate by check mark whether the
registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company i☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with
any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
On
May 27, 2021, the Shareholders of MiMedx Group, Inc. (the "Company") approved Amendment No. 1 the Company’s Bylaws (the “Proxy Access Bylaw”) to provide for proxy access, which will allow eligible shareholders (as defined in the Proxy Access Bylaw) who comply with the requirements set forth in the Bylaws to include their own nominees for director in the Company’s proxy materials along
with the candidates nominated by the Board. A description of the Proxy Access Bylaw and a copy the Proxy Access Bylaw were included in the Company’s Definitive Proxy Statement filed with the SEC on April 30, 2021 and are incorporated herein by reference. Following approval by the shareholders, the Proxy Access Bylaw became effective on May 27, 2021. The preceding summary is qualified in its entirety by reference to the Proxy Access Bylaw,
which is filed hereto as Exhibit 3.1 to this Current Report on Form 8-K and incorporated herein by reference.
Item 5.07 Submission of Matters to a Vote of Security Holders.
On May 27, 2021, the Company held its 2021 Annual Meeting of shareholders (the “2021 Annual Meeting”). At the 2021 Annual Meeting, shares of Company common stock and Series B Preferred Stock representing 99,585,181 votes (i.e., approximately 75.7% of the votes entitled to be cast at the 2021 Annual Meeting) were represented in person or by proxy.
At
the 2021 Annual Meeting, shareholders of the Company: (1) elected M. Kathleen Behrens, K. Todd Newton, and Timothy R. Wright as Class II directors; (2) elected Phyllis Gardner as a Class III director; (3) approved an advisory resolution regarding executive compensation; (4) ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021; (5) approved an amendment to the Articles to declassify the board of directors of the Company (the “Board”); (6) approved an amendment to the Articles to reduce the ownership threshold to call a special shareholders’ meeting;
and (7) approved an amendment to the Company’s Bylaws to adopt proxy access. Set forth below is information regarding the votes cast for each proposal:
Proposal 1: Election of Class II Directors.
For
Abstain/ Withhold
Broker Non-Votes
M.
Kathleen Behrens
66,034,419
2,771,640
30,779,122
K. Todd Newton
67,793,538
1,012,521
30,779,122
Timothy R. Wright
65,517,328
3,288,731
30,779,122
Proposal 2: Election of Class III Director.
For
Abstain/ Withhold
Broker
Non-Votes
Phyllis Gardner
57,920,747
10,883,717
30,779,122
Proposal 3: Advisory approval of executive compensation.
For
Against
Abstain
Broker
Non-Votes
51,552,916
14,557,553
2,695,590
30,779,122
Proposal 4: Ratification of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021;
For
Against
Abstain
Broker
Non-Votes
98,912,496
547,736
124,949
N/A
Proposal 5: Approved of an amendment to the Articles to declassify the Board.
For
Against
Abstain
Broker
Non-Votes
67,640,744
1,001,646
163,669
30,779,122
Proposal 6: Approval of an amendment to the Articles to reduce the ownership threshold to call a special shareholders’ meeting.
For
Against
Abstain
Broker
Non-Votes
67,315,117
1,295,932
195,010
30,779,122
Proposal 7: Approval of an amendment to the Company’s Bylaws to adopt proxy access.
The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.
SIGNATURES
Pursuant to the requirements of the Exchange Act, the Registrant
has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
